Company Monitoring Page for Vivus

latest headlines for company on cafepharma

Six Trades on FDA, Clinical Trial Binary Events
Seeking Alpha
Tue, 07/13/10 - 09:14 pm
Tags:
BioSante, LibiGel, testosterone, EntreMed, ENMD-2076, cancer, Protalix BioTherapeutics, UPLYSO, ovarian cancer, Vivus, Qnexa, obesity, EMD 640744, cancer vaccines
Shares of obesity drugmakers rise ahead of panel
Yahoo/AP
Tue, 07/13/10 - 11:14 am
Tags:
obsesity, diet drugs, advisory panels, FDA, Qnexa, Vivus, Arena Pharmaceuticals, Contrave, Orexigen
Vivus Weight-Loss Pill Works - FDA
TheStreet.com
Tue, 07/13/10 - 08:43 am
Tags:
FDA, diet drugs, obesity, Vivus, advisory panels, Qnexa, Arena Pharmaceuticals, Orexigen, Contrave
Why the FDA Will Likely Reject 3 New Weight Loss Drugs
BNET Pharma
Mon, 07/12/10 - 02:39 pm
Tags:
FDA, Vivus, obesity, Qnexa, Orexigen, Arena Pharmaceuticals, Contrave
Avandia, Qnexa Mean a Big Week for FDA Advisory Committee
WSJ Online
Mon, 07/12/10 - 10:24 am
Tags:
Qnexa, Avandia, FDA, GSK, diabetes, obesity, advisory panels, Vivus
Rodman & Renshaw lowers Vivus to 'Market Perform'
Yahoo/AP
Sat, 07/10/10 - 11:18 am
Tags:
obesity, Qnexa, Vivus
Onyx, Vivus rise on ratings boost
MarketWatch
Sat, 07/10/10 - 11:12 am
Tags:
ONYX Pharmaceuticals, Vivus
Biotech Stock Mailbag: Somaxon
TheStreet.com
Fri, 07/9/10 - 12:27 pm
Tags:
Somaxon, Dendreon, Arena Pharmaceuticals, Orexigen, Vivus, Roche, GSK, Immunogen
How to Trade on an FDA Advisory Panel
Minyanville
Fri, 07/9/10 - 11:38 am
Tags:
FDA, advisory panels, Qnexa, Arena Pharmaceuticals, Vivus, Orexigen
Biotech Milestones to Watch in Q3: Obesity Drugs, Genetic Testing and More
BNET Pharma
Wed, 07/7/10 - 09:36 am
Tags:
Vivus, Qnexa, Myriad, Genomic Health, NicOx, naproxcinod, Savient, Krystexxa, Novartis, Gilenia, Seattle Genetics, Gilead Sciences, Chelsea Therapeutics, Eisai
Mark Your Calendars: Obesity Drugs Take Center Stage
Motley Fool
Sat, 06/26/10 - 09:17 am
Tags:
obesity, Orexigen, Qnexa, Vivus, Abbott Laboratories, GSK, Meridia, Alli
The Skinny on the Qnexa FDA Advisory Meeting
Minyanville
Thu, 06/24/10 - 02:55 pm
Tags:
FDA, Qnexa, obesity, Vivus, advisory panels
Buy Vivus Bullish Options Before Review of Obesity Drug, JPMorgan Advises
Bloomberg
Wed, 06/23/10 - 10:57 am
Tags:
Vivus, obesity
There Is Life After Death, At Least In Biotech
Investopedia
Tue, 06/22/10 - 10:35 am
Tags:
biotech, Celgene, Genzyme, Gilead Sciences, Isis Pharmaceuticals, Vivus, Neurocrine, Nektar
Will the Obesity Epidemic Spur a New ED Pill Just for Diabetics? One Drug Company Seems to Think So
BNET Pharma
Wed, 06/9/10 - 09:15 am
Tags:
Vivus, obesity, diabetes, Avanafil, erectile dysfunction
Vivus says erectile dysfunction drug meets goals
Yahoo/AP
Mon, 06/7/10 - 10:53 am
Tags:
erectile dysfunction, Vivus, Avanafil, diabetes
Drug stocks end dismal May with another loss
MarketWatch
Sat, 05/29/10 - 09:21 am
Tags:
Cubist Pharmaceuticals, Vivus, Arca pharmaceutical index
The race to discover Viagra for women
The Guardian, UK
Sun, 04/25/10 - 11:32 am
Tags:
Vivus, Alista, female sexual dysfunction
New Obesity Pills: The Pipeline Getting Fat?
CNBC
Tue, 04/13/10 - 09:42 am
Tags:
obesity, Vivus, Qnexa, Arena Pharmaceuticals, Orexigen, Contrave
14 Biotech Stocks Facing FDA Approval
TheStreet.com
Wed, 04/7/10 - 10:01 am
Tags:
Cell Therapeutics, Pozen, AstraZeneca, Dendreon, InterMune, Questcor Pharmaceuticals, Novartis, Biogen Idec, Teva Pharmaceuticals, Merck Serono, Savient, Javelin, Alexza, Human Genome, Jazz Pharmaceuticals, Arena Pharmaceuticals, Vivus, Biodel

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.